Back to search

Article

A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity

2022-02-15

Abstract excerpt

<title>Abstract</title> <p>Background Colorectal cancer (CRC) is one of the most common malignancies and the patient survival rate remains unacceptably low. The anti-programmed cell death-1 (PD-1)/programmed cell death ligand 1 (PD-L1) antibody-based immune checkpoint inhibitors have been added to CRC treatment regimens, however, only a fraction of patients benefits. As an important co-stimulatory molecule, 4-1B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5e8d724-9003-5226-b3a6-578958e8c654
DOI
10.21203/rs.3.rs-1352893/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicityDOI 10.21203/rs.3.rs-1352893/v1
Select a neighboring publication to make it the new centre.